Publication date: 1 December 2026 Source: Drug and Alcohol Dependence, Volume 289 Author(s): Lillyan T. Shelley, Amy M. Yule, Timothy E. Wilens, Antonio A. Morgan-López, Ty A. Ridenour, Mira Stone, Lynn E. Fiellin, Kym Ahrens, Danica K. Knight
Impulse control as a mediator between mental health and substance use across diverse adolescent and young adult samples. // Drug and Alcohol Dependence. – URL: https://www.sciencedirect.com/science/article/pii/S0376871626003996?dgcid=rss_sd_all
Impulse control as a mediator between mental health and substance use across diverse adolescent and young adult samples. Drug and Alcohol Dependence. https://www.sciencedirect.com/science/article/pii/S0376871626003996?dgcid=rss_sd_all
“Impulse control as a mediator between mental health and substance use across diverse adolescent and young adult samples.” Drug and Alcohol Dependence.
@article{article43407,
title = {Impulse control as a mediator between mental health and substance use across diverse adolescent and young adult samples},
journal = {Drug and Alcohol Dependence},
url = {https://www.sciencedirect.com/science/article/pii/S0376871626003996?dgcid=rss_sd_all}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...